Corient Private Wealth’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
171,719
+99,236
| +137% | +$1.53M | ﹤0.01% | 988 |
|
|
2025
Q1 | $1.08M | Sell |
72,483
-52,425
| -42% | -$780K | ﹤0.01% | 1240 |
|
|
2024
Q4 | $1.65M | Buy |
124,908
+16,311
| +15% | +$216K | ﹤0.01% | 1074 |
|
|
2024
Q3 | $1.54M | Buy |
108,597
+40,586
| +60% | +$577K | ﹤0.01% | 1190 |
|
|
2024
Q2 | $880K | Buy |
68,011
+4,265
| +7% | +$55.2K | ﹤0.01% | 1369 |
|
|
2024
Q1 | $885K | Sell |
63,746
-10,496
| -14% | -$146K | ﹤0.01% | 1350 |
|
|
2023
Q4 | $1.06M | Sell |
74,242
-2,889
| -4% | -$41.2K | ﹤0.01% | 1267 |
|
|
2023
Q3 | $1.2M | Buy |
77,131
+3,383
| +5% | +$52.8K | ﹤0.01% | 1124 |
|
|
2023
Q2 | $1.16M | Sell |
73,748
-8,147
| -10% | -$128K | ﹤0.01% | 1094 |
|
|
2023
Q1 | $1.35M | Buy |
81,895
+66,490
| +432% | +$1.1M | ﹤0.01% | 975 |
|
|
2022
Q4 | $240K | Buy |
+15,405
| New | +$240K | ﹤0.01% | 1416 |
|